Secondary Logo

Institutional members access full text with Ovid®

Surgery Is Not Superior to Dilation for the Management of Vaginal Agenesis in Mayer-Rokitansky-Küster-Hauser Syndrome

A Multicenter Comparative Observational Study in 131 Patients

Cheikhelard, Alaa; Bidet, Maud; Baptiste, Amandine; Viaud, Magali; Fagot, Christine; Khen-Dunlop, Naziha; Louis-Sylvestre, Christine; Sarnacki, Sabine; Touraine, Philippe; Elie, Caroline; Aigrain, Yves; Polak, Michel for the French MRKH Study Group

Obstetrical & Gynecological Survey: February 2019 - Volume 74 - Issue 2 - p 79–80
doi: 10.1097/OGX.0000000000000644
GYNECOLOGY: UROGYNECOLOGY
Buy

(Abstracted from Am J Obstet Gynecol 2018;219:281.e1–281.e9)

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a rare congenital condition characterized by vaginal agenesis, which impairs sexuality and has a negative impact on quality of life (QOL). Classic management of this condition is to create a cavity allowing satisfying painless penetrative intercourse.

Departments of Pediatric Surgery and Urology (A.C., N.K.-D., S.S., Y.A.), Department of Pediatric Endocrinology, Gynecology, and Diabetology (M.B., M.V., C.F., M.P.), National Reference Center for Rare Gynecological Diseases (PGR) (A.C., M.B., M.V., Y.A.), and Clinical Research Unit/Clinical Investigation Center (A.B., C.E.), Assistance Publique–Hôpitaux de Paris, Hôpital Necker; Université Paris Descartes (N.K.-D., S.S., Y.A., M.P.); Department of Obstetrics and Gynecology, Institut Mutualiste Montsouris (C.L.-S.); Department of Endocrinology and Reproductive Medicine, Assistance Publique–Hôpitaux de Paris, Institut Endocrinologie, Médecine Interne et Maladies Métaboliques, Hôpital Pitié-Salpêtrière (P.T.); and Médecine Sorbonne Université (P.T.), Paris, France

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.